RGC
CVS icon

Roberts, Glore & Co’s CVS Health CVS Stock Holding History

Roberts, Glore & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,407
Closed -$647K – 204
2024
Q4 		$647K Sell
14,407
-16,156
-53% -$906K 0.19% 109
2024
Q3 		$1.92M Sell
30,563
-2,330
-7% -$136K 0.56% 45
2024
Q2 		$1.94M Buy
32,893
+2,438
+8% +$153K 0.59% 46
2024
Q1 		$2.43M Sell
30,455
-50
-0.2% -$3.82K 0.73% 33
2023
Q4 		$2.41M Buy
30,505
+2,114
+7% +$150K 0.75% 34
2023
Q3 		$1.98M Buy
28,391
+1,745
+7% +$124K 0.65% 40
2023
Q2 		$1.84M Buy
26,646
+2,760
+12% +$196K 0.59% 44
2023
Q1 		$1.77M Buy
23,886
+1,170
+5% +$98.1K 0.59% 43
2022
Q4 		$2.12M Sell
22,716
-422
-2% -$40.7K 0.73% 38
2022
Q3 		$2.21M Sell
23,138
-435
-2% -$43.1K 0.79% 33
2022
Q2 		$2.18M Sell
23,573
-300
-1% -$29.3K 0.73% 38
2022
Q1 		$2.42M Sell
23,873
-100
-0.4% -$10.5K 0.7% 41
2021
Q4 		$2.47M Buy
23,973
+1,030
+4% +$95.2K 0.65% 42
2021
Q3 		$1.95M Buy
22,943
+150
+0.7% +$12.6K 0.59% 47
2021
Q2 		$1.9M Buy
22,793
+190
+0.8% +$15.6K 0.57% 51
2021
Q1 		$1.7M Sell
22,603
-65
-0.3% -$4.74K 0.53% 50
2020
Q4 		$1.55M Buy
22,668
+930
+4% +$60.5K 0.51% 55
2020
Q3 		$1.27M Buy
21,738
+1,604
+8% +$99.8K 0.45% 56
2020
Q2 		$1.31M Buy
20,134
+355
+2% +$22.4K 0.51% 53
2020
Q1 		$1.17M Buy
19,779
+360
+2% +$24K 0.5% 54
2019
Q4 		$1.44M Buy
19,419
+9,126
+89% +$641K 0.55% 53
2019
Q3 		$649K Sell
10,293
-95
-0.9% -$5.63K 0.4% 73
2019
Q2 		$566K Buy
10,388
+5,525
+114% +$298K 0.35% 78
2019
Q1 		$262K Buy
+4,863
New +$300K 0.16% 118

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Roberts, Glore & Co's CVS Position: Q1 2025 in Review

Roberts, Glore & Co sold out of CVS Health (CVS) in Q1 2025, closing a stake of 14,407 shares — an estimated $647K sold.

Roberts, Glore & Co first reported a position in CVS in Q1 2019 and held it in 24 quarters. The position peaked at $2.47M in Q4 2021. 1,753 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Roberts, Glore & Co reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Roberts, Glore & Co sold 14,407 CVS Health shares in Q1 2025, an estimated $647K.
  • Roberts, Glore & Co first reported a position in CVS Health in Q1 2019 and held it in 24 quarters.
  • Roberts, Glore & Co's CVS Health position peaked at $2.47M in Q4 2021.
  • 1,753 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Roberts, Glore & Co's 13F filing for Q1 2025, filed 9 May 2025.